Home Data Calendar Blog

DNLI

Tables

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30
Common Stock Value 1.561.561.551.551.541.541.541.531.521.391.381.291.291.281.281.271.271.261.251.20NANA
Weighted Average Number Of Diluted Shares Outstanding 123.47123.01122.67NA121.74121.29120.88NA107.49105.72102.42NANANANANANANANANANANA
Weighted Average Number Of Shares Outstanding Basic 123.47123.01122.67NA121.74121.29120.88NA107.49105.72102.42NANANANANANANANANANANA
Earnings Per Share Basic -0.84-0.48-0.53-0.62-0.69-0.50-0.582.30-0.54-0.56-0.55NANANANA0.82-0.38-0.59-0.26NANANA
Earnings Per Share Diluted -0.84-0.48-0.53-0.62-0.69-0.50-0.582.28-0.54-0.56-0.55NANANANA0.79-0.38-0.59-0.26NANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30
Revenue From Contract With Customer Excluding Assessed Tax 0.1852.4842.1412.515.2922.947.92316.819.395.813.554.6713.604.204.21125.681.201.650.640.000.000.00
Revenues 3.5652.4842.1412.515.2922.947.92316.819.395.853.604.6713.604.204.21125.681.201.650.640.000.000.00
Operating Expenses 111.05113.90108.6489.6490.8884.7679.1472.7469.5167.1263.5762.4363.7666.9646.7150.9539.1659.0326.3923.5422.2922.57
Research And Development Expense 87.7992.7486.1067.8871.5665.7160.2154.7453.7053.1551.0251.5552.5451.8837.4039.9130.3252.1320.8218.4718.5219.00
General And Administrative Expense 23.2621.1622.5421.7619.3219.0518.9417.9915.8013.9712.5510.8811.2115.089.3111.048.846.905.575.073.773.56
Operating Income Loss -107.49-61.42-66.50-77.12-85.59-61.82-71.22244.08-60.12-61.28-59.97-57.76-50.16-62.76-42.5174.72-37.96-57.38-25.75-23.54-22.29-22.57
Allocated Share Based Compensation Expense 24.5823.9426.1422.0921.0021.1421.0313.8313.2512.4810.798.898.9013.716.875.655.514.712.921.461.131.06
Income Tax Expense Benefit 0.000.03NANANANANANA0.060.08-0.140.07-0.11-0.310.000.000.000.00NANANANA
Net Income Loss -103.30-58.79-65.22-75.26-84.59-60.69-70.04244.88-58.23-58.76-56.76-54.02-46.26-58.34-38.9977.53-35.37-54.72-23.68-22.89-21.84-22.13
Comprehensive Income Net Of Tax -102.88-61.82-71.97-77.24-84.74-60.83-70.03244.63-58.77-59.04-56.28-54.24-46.58-57.79-38.0178.30-35.29-54.93-24.60-23.02-21.70-22.12

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30
Assets 1227.611292.461320.861404.161449.971509.821547.861604.281070.31647.34695.87553.23602.98637.60676.60661.98544.48572.05613.95486.72NANA
Liabilities 416.30408.01402.93441.87437.69437.11442.50453.75187.76145.17150.55158.34164.78162.43159.95115.1483.3081.7874.9220.93NANA
Liabilities And Stockholders Equity 1227.611292.461320.861404.161449.971509.821547.861604.281070.31647.34695.87553.23602.98637.60676.60661.98544.48572.05613.95486.72NANA
Stockholders Equity 811.30884.45917.93962.291012.281072.701105.351150.53882.55502.17545.31394.89438.20475.17516.65546.85461.18490.27539.03465.80NANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30
Assets Current 1138.531114.60988.44897.231055.511341.741431.621495.65970.87559.41604.78430.03494.38495.98499.53480.84383.40377.42377.42409.61NANA
Cash And Cash Equivalents At Carrying Value 118.61155.09104.95293.48394.55485.68435.32507.14351.05137.18207.5479.4582.6762.9439.6677.1243.6533.0944.00218.3836.2741.31
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 120.11156.59106.45294.98396.05487.18436.82508.64352.55138.68209.0480.9584.1764.4441.1678.6245.1534.5944.45218.9136.8041.84
Marketable Securities Current 987.44913.58852.57571.93644.62823.25977.83962.55610.15412.40379.71335.91396.72415.67445.82387.17331.31339.50329.40187.85NANA
Prepaid Expense And Other Assets Current 32.4745.5830.9130.6015.1416.0315.9620.289.669.8317.5414.6814.9917.3814.0516.548.454.834.023.38NANA
Available For Sale Securities Debt Securities 987.441007.801102.84997.38964.09915.771016.71995.25630.50419.63389.40375.79420.25471.50543.37535.05473.48518.21NA248.60NANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30
Property Plant And Equipment Net 41.6938.7037.6838.8740.0140.3541.3840.8542.2743.6245.4546.7347.4847.2036.9525.1616.2513.3214.8614.92NANA
Other Assets Noncurrent 16.1215.1814.2111.873.783.583.742.463.863.772.322.663.243.958.158.112.652.612.271.44NANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30
Liabilities Current 360.67348.16341.24378.2554.2551.4154.6171.70105.4158.4647.6345.3446.6946.5543.2432.7931.6231.0117.1714.16NANA
Accounts Payable Current 7.547.123.364.784.824.241.631.072.811.872.322.592.023.933.661.893.359.181.382.72NANA
Contract With Customer Liability Current 0.02NANA27.911.325.7512.8919.9128.0234.1324.6718.7418.1822.6023.1511.4312.668.718.430.00NANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30
Other Liabilities Noncurrent 0.380.380.380.380.700.700.700.700.380.380.380.380.390.410.440.470.120.160.190.47NANA
Operating Lease Liability Noncurrent 54.9855.5257.0958.5559.9961.4062.9264.1765.4166.6167.7968.8669.9270.9171.41NANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30
Stockholders Equity 811.30884.45917.93962.291012.281072.701105.351150.53882.55502.17545.31394.89438.20475.17516.65546.85461.18490.27539.03465.80NANA
Common Stock Value 1.561.561.551.551.541.541.541.531.521.391.381.291.291.281.281.271.271.261.251.20NANA
Additional Paid In Capital 1693.901664.171635.841608.241580.991556.681528.501503.661480.321041.301025.41818.80807.88798.28781.97774.16766.80760.61754.44656.66NANA
Retained Earnings Accumulated Deficit -872.31-769.01-710.22-645.00-569.74-485.15-424.46-354.42-599.30-541.07-482.31-425.55-371.53-325.27-266.93-227.94-305.47-270.10-215.38-191.70NANA
Accumulated Other Comprehensive Income Loss Net Of Tax -11.85-12.27-9.25-2.50-0.52-0.37-0.23-0.240.010.550.830.350.560.880.33-0.65-1.42-1.49-1.29-0.37NANA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 24.5823.9426.1422.0921.0021.1421.0313.8313.2512.4810.798.898.9013.716.875.655.514.712.92NANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30
Net Cash Provided By Used In Operating Activities -57.05-42.90-72.11-65.49-41.43-54.22-50.24513.910.09-43.36-54.49-47.64-30.43-43.17-30.3293.19-34.82-41.8233.58-18.34NANA
Net Cash Provided By Used In Investing Activities 15.4288.63-117.88-40.75-53.0197.54-25.41-367.34-212.12-30.41-13.3342.3849.4963.88-8.05-61.4044.7330.53-301.27-95.1516.5322.07
Net Cash Provided By Used In Financing Activities 5.154.401.465.173.317.043.829.52425.903.42195.912.030.682.570.911.690.661.4393.24295.59NANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30
Net Cash Provided By Used In Operating Activities -57.05-42.90-72.11-65.49-41.43-54.22-50.24513.910.09-43.36-54.49-47.64-30.43-43.17-30.3293.19-34.82-41.8233.58-18.34NANA
Net Income Loss -103.30-58.79-65.22-75.26-84.59-60.69-70.04244.88-58.23-58.76-56.76-54.02-46.26-58.34-38.9977.53-35.37-54.72-23.68-22.89-21.84-22.13
Depreciation Depletion And Amortization 2.142.072.082.092.192.202.112.122.162.152.112.061.891.642.402.382.331.850.85NANANA
Increase Decrease In Accounts Payable 1.900.841.25-0.080.782.380.62-1.770.89-0.45-0.290.57-0.84-0.661.97-1.76-5.868.04-0.95-0.110.760.27
Share Based Compensation 24.5823.9426.1422.0921.0021.1421.0313.8313.2512.4810.798.898.9013.716.875.655.514.712.921.461.131.06

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30
Net Cash Provided By Used In Investing Activities 15.4288.63-117.88-40.75-53.0197.54-25.41-367.34-212.12-30.41-13.3342.3849.4963.88-8.05-61.4044.7330.53-301.27-95.1516.5322.07
Payments To Acquire Property Plant And Equipment 6.052.894.043.051.880.772.801.200.710.320.882.772.8510.272.031.440.850.570.541.070.370.57

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30
Net Cash Provided By Used In Financing Activities 5.154.401.465.173.317.043.829.52425.903.42195.912.030.682.570.911.690.661.4393.24295.59NANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30
Revenues 3.5652.4842.1412.515.2922.947.92316.819.395.853.604.6713.604.204.21125.681.201.650.640.000.000.00
Biogen 0.180.482.231.190.860.790.89NANANANANANANANANANANANANANANA
Sanofi Collaboration Agreement 3.3840.00NA0.000.0015.000.000.050.120.310.591.2512.523.463.52123.480.000.000.00NANANA
Takeda Collaboration Agreement 0.0012.0039.9211.324.427.147.039.339.275.543.023.421.080.740.682.191.201.650.64NANANA
Revenue From Contract With Customer Excluding Assessed Tax 0.1852.4842.1412.515.2922.947.92316.819.395.813.554.6713.604.204.21125.681.201.650.640.000.000.00
Sanofi, Milestone Triggered, Subsequent Event, Collaborative Arrangement NANANANANANANANANANANANANANANANANANANANANANA
Sanofi, Milestone Triggered, Collaborative Arrangement 0.0040.00NANA0.0015.00NANA0.000.00NANANANANANANANANANANANA
Takeda Pharmaceutical Company Limited, Milestone Triggered, Collaborative Arrangement NA12.0012.000.000.000.00NANANANANANANANANANANANANANANANA
Takeda Pharmaceutical Company Limited, Option Fee Payment, Collaborative Arrangement P T V P G R N And A T V T R E M2 0.00NANANANANANANANANANANANANANANANANANANANANA
Takeda Pharmaceutical Company Limited, Collaborative Arrangement A T V Tau NANA27.90NANANANANANANANANANANANANANANANANANANA
Takeda Pharmaceutical Company Limited, Collaborative Arrangement 0.000.0012.00NANANANANANA0.000.00NANANANANANANANANANANA
C N S Program License, Sanofi Collaboration Agreement 0.0040.00NANANANANANANANANANANANANANANANANANANANA
Collaboration Agreement Services, Takeda Collaboration Agreement 0.0012.0039.921.324.427.147.03NANANANANANANANANANANANANANANA
Option Services, Biogen 0.180.482.231.190.860.790.89NANANANANANANANANANANANANANANA

Plots across concepts


IncomeStatement
Operating Income Loss
Expenses
Income Tax Expense Benefit
Balance Sheet
Operating Lease Right Of Use Asset
Assets
Operating Lease Right Of Use Asset
Current Assets
Prepaid Expense And Other Assets Current
NonCurrent Assets
Other Assets Noncurrent
Liabilities
Derivative Liabilities
Current Liabilities
Contract With Customer Liability Current
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Income Loss
NetCashProvidedByUsedInOperatingActivities
Net Income Loss
NetCashProvidedByUsedInInvestingActivities
Payments To Acquire Property Plant And Equipment
Shares
Weighted Average Number Of Diluted Shares Outstanding
OperatingLeaseLiability
Operating Lease Liability Current
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year

Line plots across dimensions of each concept


TTM Greenblatt ROC
_
(None,)
T T M  Greenblatt  R O C_
us-gaap:Revenues
us-gaap:TypeOfArrangement
(None,)
Revenuesus-gaap: Type Of Arrangement
us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation
(None,)
Allocated Share Based Compensation Expenseus-gaap: Income Statement Location
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:PrepaidExpenseAndOtherAssetsCurrent
us-gaap:CounterpartyName, us-gaap:TypeOfArrangement
('dnli:TakedaPharmaceuticalCompanyLimited', None)
Prepaid Expense And Other Assets Currentus-gaap: Counterparty Name, us-gaap: Type Of Arrangement
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FinancialInstrument, us-gaap:InvestmentType
(None, 'us-gaap:ShortTermInvestments')
Available For Sale Securities Debt Securitiesus-gaap: Financial Instrument, us-gaap: Investment Type
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:InvestmentType
(None,)
Available For Sale Securities Debt Securitiesus-gaap: Investment Type
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:BalanceSheetLocation, us-gaap:FinancialInstrument
('dnli:ShortTermMarketableSecurities', None)
Available For Sale Securities Debt Securitiesus-gaap: Balance Sheet Location, us-gaap: Financial Instrument
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:Revenues
us-gaap:TypeOfArrangement
(None,)
Revenuesus-gaap: Type Of Arrangement